The new pharmaceutical pricing reforms leave many controls in place, sparking questions on the objective of the changes. Here we push past the fog to see what's really going on
The new pharmaceutical pricing reforms leave many controls in place, sparking questions on the objective of the changes. Here we push past the fog to see what's really going on
Which FTZ should I invest in and which sectors are off limits? Are the zones really more liberal towards foreign investment in practice? What are the administrative and approval procedures to set up a company?
The new Foreign Investment Industrial Guidance Catalogue has opened up and closed off a number of key industries accessible to overseas investors. It may be the last version as China moves to further reform the FDI framework
The latest Drug Administration Law amendments introduce welcome changes such as relaxed permit requirements and free prices. Pharmaceutical companies should keep abreast of the drug pricing reform, and track review and approval changes in the pipeline
The latest Drug Administration Law amendments introduce welcome changes such as relaxed permit requirements and free prices. Pharmaceutical companies should keep abreast of the drug pricing reform, and track review and approval changes in the pipeline